Live consignments reclassified as ascorbic acid; anti-dumping duty and confiscation upheld, past consignments largely allowed, director penalties set aside

CESTAT CHENNAI - AT held the impugned order validly classified the 'live' consignments as ascorbic acid (CTH 2936.27) rather than ascorbyl polyphosphate, attracting anti-dumping duty and lawful confiscation for misdeclaration. For past consignments, absence of testing and supplier analysis meant misdeclaration was not conclusively proved and many consignments were correctly found eligible as feed additives under the notification. Penalties against company directors were set aside for lack of proof of personal culpability; the penalty under the provision requiring mens rea against the company was also quashed. Refund/adjustment relief ordered after dues are reconciled.

---

---

ISSUES PRESENTED AND CONSIDERED

1. Whether the two 'live' consignments declared as "Ascorbyl Polyphosphate" were mis-declared and correctly reclassified as Ascorbic Acid, attracting anti-dumping duty, confiscation and related duties/interest.

2. Whether six past consignments declared as "Ascorbyl Polyphosphate" and other past imports were mis-declared or mis-classified such that duty demands (including under the extended period) are sustainable.

3. Whether Amprolium HCL, Lincomycin 11% (feed grade) and Tiamulin Hydrogen Fumarate 20% (feed grade) were correctly classified and whether exemptions under the relevant notification were properly allowed or denied.

4. Whether penalties under the Customs Act are imposable on company officers (Director and Managing Director) under Section 112(a) for acts rendering goods liable to confiscation.

5. Whether penalty under Section 114A is sustainable against the importing company for alleged willful mis-statement or suppression of facts.

ISSUE-WISE DETAILED ANALYSIS

Issue 1 - Mis-declaration of the two 'live' consignments as Ascorbyl Polyphosphate vs. Ascorbic Acid

Legal framework: Classification under Customs Tariff Headings determines duty; Sections 17(2)/144 permit chemical testing; Section 111(m) provides for confiscation where goods do not correspond with declared particulars; Section 125 permits redemption on payment of fine; anti-dumping notifications impose additional duties.

Precedent treatment: The Court relied on established principles distinguishing in rem action against goods and the necessity of reliance on authoritative laboratory tests unless convincingly challenged; authorities confirming that conditional imports not meeting prescribed conditions may be treated as prohibited for confiscation purposes were followed.

Interpretation and reasoning: Uncontested CRCL chemical analyses showed =99% ascorbic acid content; supplier COO/HS documentation and chemical distinctions (molecular formulas, stability, intended uses) demonstrate that Ascorbyl Polyphosphate and Ascorbic Acid are chemically and tariff-wise distinct and not interchangeable. The importer did not successfully rebut the laboratory findings. Mis-declaration affected duty incidence and eligibility for notification benefits and, given the regulatory conditions and anti-dumping measures applicable to imports from the stated origin, the goods were liable to confiscation under Section 111(m).

Ratio vs. Obiter: Ratio - authoritative lab tests and uncontested chemical evidence support reclassification and confiscation; Obiter - discussion of commercial arrangements and supplier practices as indicia of modus operandi.

Conclusion: Reclassification to Ascorbic Acid, confirmation of anti-dumping and customs duty demands, and confiscation under Section 111(m) (with option to redeem on payment of fine) are upheld; the redemption fine was prorated between the two BEs for administrability.

Issue 2 - Past consignments declared as Ascorbyl Polyphosphate: sustainment of duty demands under extended period

Legal framework: Burden lies on revenue to prove taxability; extended period demands require proof of deliberate suppression or circumstances justifying extended limitation. Evidence rules require proof beyond suspicion; laboratory testing/technical opinion necessary where composition is disputed.

Precedent treatment: Principles that strong suspicion/strange coincidences cannot substitute for legal proof and that the revenue must discharge its burden of proof were applied.

Interpretation and reasoning: No chemical tests or supplier analyses were produced for the six past consignments; reliance on pattern from live consignments and COO HS codes alone was insufficient to prove mis-declaration. Visual inspection and administrative clearances without testing do not establish composition. In absence of proof of willful misstatement or suppression, extended-period demands cannot be sustained.

Ratio vs. Obiter: Ratio - demand for duty in respect of the six past consignments is set aside for lack of proof; Obiter - observations on the insufficiency of COO/appearance as conclusive proof.

Conclusion: Duty demands (including extended period) on the six past consignments described as Ascorbyl Polyphosphate are quashed for want of proof.

Issue 3 - Classification of Amprolium HCL, Lincomycin 11% and Tiamulin Hydrogen Fumarate 20%

Legal framework: Classification is to be determined by the tariff text and explanatory notes; end-use is irrelevant where a tariff entry is defined by commodity characteristics; notification benefits apply as per tariff description.

Precedent treatment: Authorities that separate chemically defined compounds fall under chemical chapters rather than feed-preparation headings and that end-use cannot govern classification when tariff entries are otherwise clear were followed.

Interpretation and reasoning: Amprolium HCL (98% purity) is a chemically defined heterocyclic compound falling under chapter 29 and not a premix/feed preparation under heading 2309; supplier analysis supported pharmaceutical/pure chemical character. For Lincomycin 11% and Tiamulin hydrogen fumarate 20%, supplier composition showed they are preparations with carriers and other ingredients consistent with feed premixes under 2309. Accordingly, the denial of benefit under Sl. No. 52 and grant under Sl. No. 572 (as applicable) were held correct.

Ratio vs. Obiter: Ratio - Amprolium HCL correctly classed under CTH 2933 and duties confirmed; Lincomycin and Tiamulin correctly treated as feed premixes eligible under the feed-related notification entry; Obiter - comment that commercial sale to feed manufacturers does not by itself alter classification.

Conclusion: Classification and resulting duty treatment for Amprolium HCL upheld; grant of exemption under the feed-premix notification entry for Lincomycin and Tiamulin is correct and duty recalculated accordingly.

Issue 4 - Penalties on company officers under Section 112(a)

Legal framework: Section 112(a) penalizes persons who do or omit acts rendering goods liable to confiscation or who abet such acts; imposition on officers requires demonstration of their active role or that they were directing minds responsible for the offending act; mens rea need not be an element of Section 112(a), but connection of the individual to the actionable conduct is necessary.

Precedent treatment: Decisions requiring evidence of personal commission/omission or direction by officers before imposing penalties on company officials were followed; precedents emphasizing that mere corporate involvement without evidence of individual culpability is insufficient were applied.

Interpretation and reasoning: The SCN and adjudication did not evidence specific acts/omissions by the Director and Managing Director showing that they directed or participated in the mis-declaration or mis-classification. No supplier admissions, no buyer contracts showing deliberate conduct, and no admissions by the officers were produced. Absent demonstration of active involvement or guilty mind tied to the officers' conduct, imposition of personal penalties was not sustainable.

Ratio vs. Obiter: Ratio - penalties under Section 112(a) on the two officers are set aside for lack of evidence of personal culpability; Obiter - cautionary statements on standards required to attribute corporate acts to individuals.

Conclusion: Personal penalties on the Director and Managing Director under Section 112(a) are overturned.

Issue 5 - Penalty under Section 114A on the importing company

Legal framework: Section 114A prescribes penalty where duty short-levied/evaded by reason of collusion or willful mis-statement or suppression of facts; the provision requires proof of willfulness in mis-statement/suppression.

Precedent treatment: Authorities holding that "willful" denotes intention to evade and that mere misclassification without proof of intent cannot sustain Section 114A penalties were applied.

Interpretation and reasoning: The record lacks evidence of collusion or willful misstatement/suppression by the company; there is no demonstration of intent to evade duty beyond the mis-match in live consignments, and extended inferences from pattern or labeling alone do not establish willful suppression. Consequently the statutory threshold for Section 114A penalty is not met.

Ratio vs. Obiter: Ratio - Section 114A penalty on the company is set aside for absence of proof of willful mis-statement or suppression; Obiter - explanation that stricter mens rea requirement renders Section 114A inapplicable where willfulness is unproven.

Conclusion: Penalty under Section 114A against the company is quashed.

Cross-references and Consequential Directions

Interrelation: Issues of classification, confiscation and in rem action against goods are distinct from penalties against persons; successful reclassification and confiscation do not automatically sustain personal or willfulness-based penalties without specific evidence of individual or company intent.

Consequential orders: Duties, anti-dumping duty and interest on the live consignments and duties for correctly classified past consignments are to be recovered; confiscation and option to redeem (with prorated fines) are sustained; previously appropriated payments to be adjusted and affected persons are entitled to consequential relief as per law.

---